Want to track IMMX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Immix Biopharma Inc. (IMMX) Statistics
Valuation metrics
Market Cap 514.64M
Enterprise value 437.08M
Trailing P/E (ttm) -9.07
Forward P/E -
PEG ratio 0.68
Price/Sales (ttm) -
Price/Book (mrq) 2.22
Enterprise Value/Revenue -
Enterprise Value/EBITDA -10.9
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.3M
Average volume (90 days) 1.65M
Price summary
52-Week low 2.61
52-Week high 15.1
Beta -
50-Day moving average 11.4
200-Day moving average 10.22
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.17%
Return on equity -0.38%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.63
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.64
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 25.13%
Book value per share (mrq) 3.59
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
